GP develops new antimicrobials to eliminate antibiotic-resistant bacteria and hard-to-treat viruses. GP has established a platform for launching antimicrobials for use in livestock production.
Our core competency is the precise engineering of advanced probiotics. We use advanced bioengineering techniques to tailor performance probiotics that effectively target pathogens.
Our first line of products will help chicken producers produce healthy birds and distribute whole chickens and chicken parts that are not contaminated with salmonella, clostridia or campylobacter.
Our next line of products will help swine producers raise healthy pigs, free of diarrheagenic E. coli, Lawsonia intracellularis, or Streptococcus suis.
We are also working on antiviral probiotics against influenza and coronaviruses.